Today, Merck & Co. is an established top global player on the pharmaceutical market, generating nearly 60 billion U.S. dollars of revenue. The roots of Merck & Co., Inc. can be traced back to the 17th century: The company began as a purchased drug store in Darmstadt, Germany, in 1668 under Jacob Friedrich Merck. In 1891, a subsidiary became active in the United States under the name Merck & Co. Since 1917, when it was confiscated by the U.S. during the World War, Merck & Co. is an independent U.S. American company.
Merck's focus areas
The company’s products range from vaccines and cancer drugs to animal health products. As a company, Merck & Co. has one of the highest numbers of approved drugs, spending significant amounts on research and development. Two of the company's most important products are targeting diabetes, a chronic disease that plagues society. Januvia (sitagliptin) is one of the best-selling diabetes drugs globally and is popular as it does not cause weight gain. The drug generated some 2.8 billion U.S. dollars in revenue in 2022. However, blockbuster cancer drug Keytruda is currently by far Merck's leading product.
A global company
Merck & Co. is an international company, generating more than half of its revenues outside the United States. As one of the largest pharmaceutical companies in the world, Merck & Co. had some 69,000 employees in 2022, spread over 100 countries. The company had total assets accounting for around 109 billion U.S. dollars in the same year.
This text provides general information. Statista assumes no
liability for the information given being complete or correct.
Due to varying update cycles, statistics can display more up-to-date
data than referenced in the text.